Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin-Reference-Cited by-同舟云学术

Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin

Published:2007-04-04 Issue:6 Volume:52 Page:1540-1547
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Sjogren Maria H.,Sjogren Robert,Lyons Michael F.,Ryan Michael,Santoro John,Smith Coleman,Reddy K. Rajender,Bonkovsky Herbert,Huntley Brooke,Faris-Young Sima

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-007-9757-9.pdf

Reference27 articles.

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. (1999) The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341(8):556–562

2. Gish RG, Afdhal NH, Dieterich DT, Reddy KR (2005) Management of hepatitis C virus in special populations: patient and treatment considerations. Clin Gastroenterol Hepatol 3(4):311–318

3. Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatology 36(5; Suppl 1):S21–S29

4. Strader DB, Wright T, Thomas DL, Seeff LB (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology 39(4):1147–1171

5. Fried MW, Shiffman ML, Reddy KR, et al. (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347(13):975–982

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C;Encyclopedia of Cell Biology;2023

2. The A150V Polymorphism of Genotype 3 Hepatitis C Virus Polymerase Inhibits Interferon Alfa by Suppressing Protein Kinase R Activation;Cellular and Molecular Gastroenterology and Hepatology;2021

3. Reinforced reasoning in medicine;Journal of Evaluation in Clinical Practice;2020-04

4. Interferons and Their Role in Viral Infection;Dynamics of Immune Activation in Viral Diseases;2020

5. Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection;Digestive Diseases;2017